tiprankstipranks
Trending News
More News >
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market

bioAffinity Technologies, Inc. (BIAF) Financial Statements

Compare
198 Followers

bioAffinity Technologies, Inc. Financial Overview

bioAffinity Technologies, Inc.'s market cap is currently $12.33M. The company's EPS TTM is $5.98; its P/E ratio is -0.14; bioAffinity Technologies, Inc. is scheduled to report earnings on March 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 6.16M$ 9.36M$ 2.53M$ 4.80K$ 0.00
Gross Profit$ 1.43M$ 3.38M$ 791.62K$ 4.34K$ -4.82K
Operating Income$ -10.57M$ -8.95M$ -7.97M$ -4.01M$ -2.21M
EBITDA$ -10.07M$ -8.33M$ -7.63M$ -5.61M$ -5.32M
Net Income$ -14.91M$ -9.04M$ -7.94M$ -8.15M$ -6.33M
Balance Sheet
Cash & Short-Term Investments$ 6.45M$ 1.11M$ 2.82M$ 11.41M$ 1.36M
Total Assets$ 10.96M$ 6.51M$ 8.22M$ 12.18M$ 1.45M
Total Debt$ 1.16M$ 1.50M$ 1.58M$ 251.75K$ 11.36M
Net Debt$ -5.29M$ 395.90K$ -1.24M$ -11.16M$ 10.00M
Total Liabilities$ 3.68M$ 3.91M$ 3.37M$ 1.14M$ 17.24M
Stockholders' Equity$ 7.28M$ 2.60M$ 4.86M$ 11.04M$ -15.79M
Cash Flow
Free Cash Flow$ -9.33M$ -7.34M$ -6.06M$ -4.29M$ -2.05M
Operating Cash Flow$ -9.33M$ -7.26M$ -6.04M$ -4.07M$ -2.05M
Investing Cash Flow$ -60.57K$ -79.08K$ -2.21M$ -219.99K$ 0.00
Financing Cash Flow$ 14.73M$ 5.63M$ -344.98K$ 14.34M$ 3.33M
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

bioAffinity Technologies, Inc. Debt to Assets

bioAffinity Technologies, Inc. Cash Flow

bioAffinity Technologies, Inc. Forecast EPS vs Actual EPS